Tumor Cells
Tumors arise with great frequency, especially in older animals and humans, but most pose little risk to their host because they are localized and of small size. We call such tumors benign; an example is warts. It is usually apparent when a tumor is benign because it contains cells that closely resemble, and may function like, normal cells. The surface interaction molecules that hold tissues together keep benign tumor cells, like normal cells, localized to appropriate tissues. Circulating tumor cells (CTCs) are cells that have shed into the vasculature from a primary tumor and circulate in the bloodstream. CTCs thus constitute seeds for subsequent growth of additional tumors (metastasis) in vital distant organs, triggering a mechanism that is responsible for the vast majority of cancer-related deaths.
- Mast Cells
- Circulatory tumor Cells
- Germ Cell tumor
Related Conference of Tumor Cells
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
International Cancer Study Therapy Conference
Cancer and Autoimmunity 2016 Emerging Target Therapies in Cancer Autoimmunity
EMBO Conference Cellular signalling and cancer therapy
International Conference on Medical Medicine and Health Sciences MMHS- 2015 Singapore
Cancer Immunotherapy Emerging Biology Targets and Strategies Conference
International Cancer Study Therapy Conference
4th International Conference on Immunochemotherapy
International Congress of Immunology
apanese Society For Immunology 44th Annual Meeting
Tumor Immunology and Immunotherapy
ESMO Symposium on immuno-oncology
Cancer Immunotherapy Immunity and Immuno supression Meet Targeted Therapies
5th Annual Brain Metastases Research and Emerging Therapies Conference
Advanced Breast Cancer Third International Consensus Conference ABC3
Cancer Metabolism Conference Cancer Metabolism Conference
10th International Conference on Cancer
Cancer Pathophysiology Integrating the Host and Tumor Environments
Tumor Cells Conference Speakers
Recommended Sessions
- Brain Tumors
- Tumor Cells
- Tumors
- Antibodies Treatment:Cancer
- Cancer biomarkers
- Cancer clinical trials
- Cancer Immunology & Immunotherapy
- Cancer micro and immuno environment
- Cancer Research
- Cancer vaccines
- Combining Cancer Immunotherapies
- Engineered T-Cell Therapy
- Immune checkpoint inhibitors
- Immune System- Tumors
- Immuno-Oncology studies
- Immunotherapy - tumors
- Immunotherapy Monitoring
- Novel Approaches
- Tumor biology
- Tumor Causatives
- Tumor immunology
- Tumor immunotherapy research
- Tumor markers and drug targetting
- Tumorigenesis
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)